Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lee, S. J.
Right arrow Articles by Zelen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S. J.
Right arrow Articles by Zelen, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1199-1202, 2003
© 2003 European Society for Medical Oncology

Original Paper

Modelling the early detection of breast cancer

S. J. Lee+ and M. Zelen

Dana-Farber Cancer Institute and the Harvard School of Public Health, Boston, MA, USA

Received 12 July 2002; accepted 3 April 2003

A mathematical model was developed to predict the outcome of early detection clinical trials or programs targeted at evaluating mortality benefit from earlier diagnosis of breast cancer. The model was applied to eight randomized breast cancer trials, which were carried out to evaluate the benefits of mammography, physical examination or their combination. The model assumes that breast cancer is a progressive disease and any mortality benefit from earlier diagnosis is generated from a favorable shift in the stage at diagnosis relative to usual care. The model predicted the reduction in mortality for seven of the eight trials within the reported confidence intervals. Input data required by the models are: stage shift distribution, examination schedules, population age distribution, follow up time, and survival conditional on stage at diagnosis. Survival distributions were obtained from the 1973-82 SEER database whereas the remaining data was obtained for each of the trials. Information on sensitivity and stage was ordinarily available during the early phase of the trials. The theoretical model has the promise of being able to predict the long-term outcome of early detection trials or programs during the initial examination phase. The theoretical model is general and may be applied to other chronic diseases, which satisfy the basic assumptions.

Key words: breast cancer, clinical trials, mammography, mathematical models


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Natl Cancer Inst MonogrHome page
S. Lee and M. Zelen
Chapter 11: A Stochastic Model for Predicting the Mortality of Breast Cancer
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 79 - 86.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. White, D. L. Miglioretti, B. C. Yankaskas, B. M. Geller, R. D. Rosenberg, K. Kerlikowske, L. Saba, P. M. Vacek, P. A. Carney, D. S. M. Buist, et al.
Biennial Versus Annual Mammography and the Risk of Late-Stage Breast Cancer
J Natl Cancer Inst, December 15, 2004; 96(24): 1832 - 1839.
[Abstract] [Full Text] [PDF]

Home page
 Stat Methods Med ResHome page
S. Lee, H. Huang, and M. Zelen
Early detection of disease and scheduling of screening examinations
Statistical Methods in Medical Research, December 1, 2004; 13(6): 443 - 456.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.